Poorly differentiated colorectal adenocarcinomas show higher rates of microsatellite instability and promoter methylation of p16 and hMLH1: A study matched for T classification and tumor location

Journal of Surgical Oncology

Volumn 97, Issue 3, 2008, Pages 278-283

  Kazama, Yoshihiro ^a   Watanabe, Toshiaki ^a   Kanazawa, Takamitsu ^a   Tanaka, Junichiro ^a   Tanaka, Toshiaki ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chromosomal instability; Colorectal cancer; Loss of heterozygosity; Matched study; Methylation specific PCR

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CHROMOSOME 17P; CHROMOSOME 18P; CHROMOSOME 2P; CHROMOSOME 5Q; COLORECTAL CARCINOMA; DNA METHYLATION; FEMALE; GENE; HETEROZYGOSITY LOSS; HMLH1 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; P16 GENE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 39749093271     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20960     Document Type: Article

References (44)

1. 1 Hamilton SR, Aaltonen LA: Pathology and genetics; tumors of the digestive system. IARC 2000 ; 110–111.
2. 2 Chung CK, Zaino RJ, Stryker JA: Colorectal carcinoma: Evaluation of histologic grade and factors influencing prognosis. J Surg Oncol 1982 ; 21: 143–148.
3. 3 Umpleby HC, Bristol JB, Rainey JB, et al.: Survival of 727 patients with single carcinomas of the large bowel. Dis Colon Rectum 1984 ; 27: 803–810.
4. 4 Bjerkeset T, Morild I, Mork S, et al.: Tumor characteristics in colorectal cancer and their relationship to treatment and prognosis. Dis Colon Rectum 1987 ; 30: 934–938.
5. 5 Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancers. Nature 1997 ; 386: 623–627.
6. 6 Kawabata Y, Tomita N, Monden T, et al.: Molecular characteristics of poorly differentiated adenocarcinoma and signet‐ring‐cell carcinoma of colorectum. Int J Cancer 1999 ; 84: 33–38.
7. 7 Gafa R, Maestri I, Matteuzzi M, et al.: Sporadic colorectal adenocarcinomas with high‐frequency microsatellite instability. Cancer 2000 ; 89: 2025–2037.
8. 8 Miyakura Y, Sugano K, Konishi F, et al.: Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology 2001 ; 121: 1300–1309.
9. 9 Iino H, Fukayama M, Maeda Y, et al.: Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential. Cancer 1994 ; 73: 1324–1331.
10. 10 Kazama Y, Watanabe T, Kanazawa T, et al.: Mucinous carcinomas of the colon and rectum show higher rates of microsatellite instability and lower rates of chromosomal instability: A study matched for T classification and tumor location. Cancer 2005 ; 103: 2023–2029.
11. 11 Herman JG, Umar A, Polyak K, et al.: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998 ; 95: 6870–6875.
12. 12 Cunningham JM, Christensen ER, Tester DJ, et al.: Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998 ; 58: 3455–3460.
13. 13 Kuismanen SA, Holmberg MT, Salovaara R, et al.: Epigenetic phenotypes distinguish microsatellite‐stable and ‐unstable colorectal cancers. Proc Natl Acad Sci USA 1999 ; 96: 12661–12666.
14. 14 Merlo A, Herman JG, Mao L, et al.: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995 ; 1: 686–692.
15. 15 Gonzalez‐Zulueta M, Bender CM, Yang AS, et al.: Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995 ; 55: 4531–4535.
16. 16 Wiencke JK, Zheng S, Lafuente A, et al.: Aberrant methylation of p16INK4a in anatomic and gender‐specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev 1999 ; 8: 501–506.
17. 17 Hawkins N, Norrie M, Cheong K, et al.: CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 2002 ; 122: 1376–1387.
18. 18 Burri N, Shaw P, Bouzourene H, et al.: Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab Invest 2001 ; 81: 217–229.
19. 19 Norrie MW, Hawkins NJ, Todd AV, et al.: Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer. J Surg Oncol 2003 ; 84: 143–150.
20. 20 Toyota M, Ahuja N, Ohe‐Toyota M, et al.: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999 ; 96: 8681–8686.
21. 21 Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996 ; 87: 159–170.
22. 22 Vasen HF, Watson P, Mecklin JP, et al.: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999 ; 116: 1453–1456.
23. 23 Sobin LH: TNM, sixth edition: New developments in general concepts and rules. Semin Surg Oncol 2003 ; 21: 19–22.
24. 24 Boland CR, Thibodeau SN, Hamilton SR, et al.: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998 ; 58: 5248–5257.
25. 25 Umetani N, Sasaki S, Watanabe T, et al.: Diagnostic primer sets for microsatellite instability optimized for a minimal amount of damaged DNA from colorectal tissue samples. Ann Surg Oncol 2000 ; 7: 276–280.
26. 26 Cawkwell L, Bell SM, Lewis FA, et al.: Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 1993 ; 67: 1262–1267.
27. 27 Medintz IL, Lee CC, Wong WW, et al.: Loss of heterozygosity assay for molecular detection of cancer using energy‐transfer primers and capillary array electrophoresis. Genome Res 2000 ; 10: 1211–1218.
28. 28 Laiho P, Launonen V, Lahermo P, et al.: Low‐level microsatellite instability in most colorectal carcinomas. Cancer Res 2002 ; 62: 1166–1170.
29. 29 Nowak MA, Komarova NL, Sengupta A, et al.: The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 2002 ; 99: 16226–16231.
30. 30 Boland CR, Sato J, Appelman HD, et al.: Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nat Med 1995 ; 1: 902–909.
31. 31 Herman JG, Graff JR, Myohanen S, et al.: Methylation‐specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996 ; 93: 9821–9826.
32. 32 van Engeland M, Weijenberg MP, Roemen GM, et al.: Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer. Cancer Res 2003 ; 63: 3133–3137.
33. 33 Sugao Y, Yao T, Kubo C, et al.: Improved prognosis of solid‐type poorly differentiated colorectal adenocarcinoma: A clinicopathological and immunohistochemical study. Histopathology 1997 ; 31: 123–133.
34. 34 Takeuchi K, Kuwano H, Tsuzuki Y, et al.: Clinicopathological characteristics of poorly differentiated adenocarcinoma of the colon and rectum. Hepatogastroenterology 2004 ; 51: 1698–1702.
35. 35 Gryfe R, Kim H, Hsieh ET, et al.: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000 ; 342: 69–77.
36. 36 Ward R, Meagher A, Tomlinson I, et al.: Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 2001 ; 48: 821–829.
37. 37 Hemminki A, Mecklin JP, Jarvinen H, et al.: Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000 ; 119: 921–928.
38. 38 Kazama Y, Watanabe T, Kanazawa T, et al.: Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: Relationship to clinicopathological features. J Clin Pathol 2007 ; 60: 701–770.
39. 39 Tang R, Changchien CR, Wu MC, et al.: Colorectal cancer without high microsatellite instability and chromosomal instability—An alternative genetic pathway to human colorectal cancer. Carcinogenesis 2004 ; 25: 841–846.
40. 40 Parsons R, Myeroff LL, Liu B, et al.: Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995 ; 55: 5548–5550.
41. 41 Rampino N, Yamamoto H, Ionov Y, et al.: Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997 ; 275: 967–969.
42. 42 Zhang H, Richards B, Wilson T, et al.: Apoptosis induced by overexpression of hMSH2 or hM LH1. Cancer Res 1999 ; 59: 3021–3027.
43. 43 Goll MG, Bestor TH: Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005 ; 74: 481–514.
44. 44 Silverman LR, Demakos EP, Peterson BL, et al.: Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B. J Clin Oncol 2002 ; 20: 2429–2440.